Literature DB >> 32537151

Barriers to the wider adoption of medicinal Cannabis.

Stephen Ph Alexander1.   

Abstract

The use of Cannabis-based preparations for medicinal use has waxed and waned in the multi-millennial history of human co-existence with the plant and its cultivation. Recorded use of preparations from Cannabis is effectively as old as recorded history with examples from China, India and Ancient Egypt. Prohibition and restriction of availability allowed a number of alternatives to take the place of Cannabis preparations. However, there has been a worldwide resurgence in medicinal Cannabis advocacy from the public. Media interest has been piqued by particular evocative cases. Altogether, therefore, there is pressure on healthcare professionals to prescribe and dispense Cannabis-based preparations. This review enunciates some of the barriers which are slowing the wider adoption of medicinal Cannabis. © The British Pain Society 2020.

Entities:  

Keywords:  Cannabis; cannabidiol; cannabinoid; tetrahydrocannabinol

Year:  2020        PMID: 32537151      PMCID: PMC7265599          DOI: 10.1177/2049463720922884

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  81 in total

1.  A Survey of Hospice Professionals Regarding Medical Cannabis Practices.

Authors:  Ryan C Costantino; Natalee Felten; Marisa Todd; Terri Maxwell; Mary Lynn McPherson
Journal:  J Palliat Med       Date:  2019-05-16       Impact factor: 2.947

2.  Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.

Authors:  Marco Colizzi; Conrad Iyegbe; John Powell; Gianluca Ursini; Annamaria Porcelli; Aurora Bonvino; Paolo Taurisano; Raffaella Romano; Rita Masellis; Giuseppe Blasi; Craig Morgan; Katherine Aitchison; Valeria Mondelli; Sonija Luzi; Anna Kolliakou; Anthony David; Robin M Murray; Alessandro Bertolino; Marta Di Forti
Journal:  Schizophr Bull       Date:  2015-03-31       Impact factor: 9.306

3.  Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol.

Authors:  M Fellermeier; M H Zenk
Journal:  FEBS Lett       Date:  1998-05-08       Impact factor: 4.124

4.  Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.

Authors:  Rongrong Jiang; Satoshi Yamaori; Shuso Takeda; Ikuo Yamamoto; Kazuhito Watanabe
Journal:  Life Sci       Date:  2011-06-16       Impact factor: 5.037

5.  Antagonist-elicited cannabis withdrawal in humans.

Authors:  David A Gorelick; Robert S Goodwin; Eugene Schwilke; David M Schwope; William D Darwin; Deanna L Kelly; Robert P McMahon; Fang Liu; Catherine Ortemann-Renon; Denis Bonnet; Marilyn A Huestis
Journal:  J Clin Psychopharmacol       Date:  2011-10       Impact factor: 3.153

Review 6.  Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.

Authors:  Douglas L Boggs; Jacques D Nguyen; Daralyn Morgenson; Michael A Taffe; Mohini Ranganathan
Journal:  Neuropsychopharmacology       Date:  2017-09-06       Impact factor: 7.853

Review 7.  Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Authors:  Mary E Lynch; Fiona Campbell
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

8.  Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.

Authors:  M E Wall; B M Sadler; D Brine; H Taylor; M Perez-Reyes
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

Review 9.  Cannabis Systematics at the Levels of Family, Genus, and Species.

Authors:  John M McPartland
Journal:  Cannabis Cannabinoid Res       Date:  2018-10-01

10.  Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Authors:  Daniel I Brierley; Joe R Harman; Natasha Giallourou; Emma Leishman; Anna Emily Roashan; Ben A D Mellows; Heather B Bradshaw; Jonathan R Swann; Ketan Patel; Benjamin J Whalley; Claire M Williams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-29       Impact factor: 12.910

View more
  5 in total

1.  Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.

Authors:  Davide Fortin; Fabienne Marcellin; Patrizia Carrieri; Julien Mancini; Tangui Barré
Journal:  Front Public Health       Date:  2022-05-27

2.  Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years.

Authors:  Sara L MacPhail; Miguel A Bedoya-Pérez; Rhys Cohen; Vicki Kotsirilos; Iain S McGregor; Elizabeth A Cairns
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

3.  Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research.

Authors:  Reilly R Kayser; Margaret Haney; Helen Blair Simpson
Journal:  Front Psychiatry       Date:  2021-02-25       Impact factor: 4.157

4.  Real World Evidence in Medical Cannabis Research.

Authors:  Rishi Banerjee; Simon Erridge; Oliver Salazar; Nagina Mangal; Daniel Couch; Barbara Pacchetti; Mikael Hans Sodergren
Journal:  Ther Innov Regul Sci       Date:  2021-11-08       Impact factor: 1.778

5.  Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists.

Authors:  Juan Manuel Orjuela-Rojas; Xiomara García Orjuela; Sabina Ocampo Serna
Journal:  J Cannabis Res       Date:  2021-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.